Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Rp-3500
2. 2417489-10-0
3. Rp3500
4. Camonsertib [inn]
5. Camonsertib [usan]
6. Camonsertib (rp-3500)
7. Atr Inhibitor 4;camonsertib
8. S1z7y5g56t
9. Chembl5095260
10. Schembl23515008
11. Schembl23515085
12. Gtpl12073
13. Rp 3500 [who-dd]
14. Rp 3500
15. 8-oxabicyclo[3.2.1]octan-3-ol, 3-[6-[(3r)-3-methyl-4-morpholinyl]-1-(1h-pyrazol-3-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl]-, (3-endo)-
16. Ex-a6416
17. Nsc841442
18. Nsc-841442
19. Ms-27079
20. Cs-0226170
21. F83116
22. (1r, 5s)-3-[6-[(3r)-3-methylmorpholin-4-yl]-1-(1h-pyrazol-5-yl)pyrazolo[3, 4-b]pyridin-4-yl]-8-oxabicyclo[3.2.1]octan-3-ol
23. (1r,3r,5s)-3-{6-[(3r)-3-methylmorpholin-4-yl]-1-(1hpyrazol-3-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl}-8-oxabicyclo[3.2.1]octan-3-ol
24. (1r,3r,5s)-3-6-[(3r)-3-methylmorpholin-4-yl]-1-(1hpyrazol-3-yl)-1h-pyrazolo[3,4-b]pyridin-4-yl-8-oxabicyclo[3.2.1]octan-3-ol
25. (1r,5s)-3-[6-[(3r)-3-methylmorpholin-4-yl]-1-(1h-pyrazol-5-yl)pyrazolo[3,4-b]pyridin-4-yl]-8-oxabicyclo[3.2.1]octan-3-ol
| Molecular Weight | 410.5 g/mol |
|---|---|
| Molecular Formula | C21H26N6O3 |
| XLogP3 | 1.6 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 101 |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 628 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
14
PharmaCompass offers a list of Camonsertib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Camonsertib manufacturer or Camonsertib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Camonsertib manufacturer or Camonsertib supplier.
PharmaCompass also assists you with knowing the Camonsertib API Price utilized in the formulation of products. Camonsertib API Price is not always fixed or binding as the Camonsertib Price is obtained through a variety of data sources. The Camonsertib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2417489-10-0 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2417489-10-0, including repackagers and relabelers. The FDA regulates 2417489-10-0 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2417489-10-0 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 2417489-10-0 supplier is an individual or a company that provides 2417489-10-0 active pharmaceutical ingredient (API) or 2417489-10-0 finished formulations upon request. The 2417489-10-0 suppliers may include 2417489-10-0 API manufacturers, exporters, distributors and traders.
2417489-10-0 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2417489-10-0 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2417489-10-0 GMP manufacturer or 2417489-10-0 GMP API supplier for your needs.
A 2417489-10-0 CoA (Certificate of Analysis) is a formal document that attests to 2417489-10-0's compliance with 2417489-10-0 specifications and serves as a tool for batch-level quality control.
2417489-10-0 CoA mostly includes findings from lab analyses of a specific batch. For each 2417489-10-0 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2417489-10-0 may be tested according to a variety of international standards, such as European Pharmacopoeia (2417489-10-0 EP), 2417489-10-0 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2417489-10-0 USP).